Objectives: This study sought to analyze the incidence and risk factors of skin complications in liver transplant recipients.
Materials And Methods: Patients with skin biopsies were selected from 408 liver transplant recipients from January 1990 to December 2012 at Baskent University in Ankara, Turkey. Demographic and clinical findings including age, sex, primary liver disease, immunosuppressive therapy, and the time between transplant and cutaneous lesions were examined.
Results: There were 38 patients who had skin biopsy after liver transplantation. The mean age at transplantation was 30.5 years. The primary liver disease was hepatocellular carcinoma second to viral hepatitis in 15 patients, Wilson disease in 7 patients, cryptogenic cirrhosis in 3, familial hypercholesterolemia in 3 patients, and 1 each patients of Byler disease, Caroli disease, tyrosinemia, Budd-Chiari syndrome, congenital hepatic fibrosis, alcoholic cirrhosis, and biliary atresia. The primary disease in 3 patients were unknown. The histologic diagnosis included precancerous and cancerous lesions (n=4), infectious diseases (n=4); xanthomatous lesions (n=4); vasculopathic lesions (n=4); melanocytic lesions (n=4); benign adnexial tumors (n=2); skin atrophy (n=2); calcinosis cutis (n=2), keratinous cyst (n=2), neutrophilic dermatosis (n=2), perivascular dermatitis (n=2) and miscellaneous lesions (n=6).
Conclusions: We presented the cutaneous manifestations in liver transplant recipients. The most common skin lesion in these patients were precancerous and cancerous lesions, infectious, xanthomatous, and melanocytic lesions. The findings emphasize the importance of dermatologic screening in these patients that can provide early diagnosis and a better quality of life.
Download full-text PDF |
Source |
---|
J Surg Res
January 2025
Department of Pediatric Surgery, Phoenix Children's Hospital, Phoenix, Arizona. Electronic address:
Introduction: Pediatric liver transplantation provides substantial survival benefit. An emphasis on value-based practices has become a central theme in many surgical fields, but have not been well-studied in pediatric transplantation. Given an increasing focus on optimizing outcomes while containing costs, defining value in pediatric liver transplantation warrants investigation.
View Article and Find Full Text PDFPancreas
January 2025
Department of Surgery, Division of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, the Netherlands.
Objectives: A significant proportion of patients undergoing surgery for pancreatic ductal adenocarcinoma (PDAC) are anemic at the time of resection. In these patients, blood transfusions are omitted due to their potential negative impact on oncological outcomes. The aim of the present study was to determine the prognostic value of preoperative anemia in resected PDAC patients, irrespective of blood transfusion status.
View Article and Find Full Text PDFJ Infect Dis
January 2025
Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Italy.
Background: To assess the impact of attaining aggressive beta-lactam pharmacokinetic/pharmacodynamic (PK/PD) targets on clinical efficacy in critical orthotopic liver transplant (OLT) recipients with documented early Gram-negative infections.
Methods: OLT recipients admitted to the post-transplant ICU between June 2021 and May 2024 having documented Gram-negative infections treated with targeted therapy continuous infusion (CI) beta-lactams, and undergoing therapeutic drug monitoring (TDM)-guided beta-lactam dosing adjustment in the first 72 hours were prospectively enrolled. Free steady-state concentrations (fCss) of beta-lactams (BL) and/or of beta-lactamase inhibitors (BLI) were calculated, and aggressive PK/PD target attainment was measured.
PLoS One
January 2025
Helsinki University Hospital, Abdominal Centre, Transplantation and Liver Surgery, and University of Helsinki, Helsinki, Finland.
Background: Patients with end-stage kidney disease often prefer home-based dialysis due to higher self-efficacy, which relates to improved medical treatment adherence. Kidney transplantation (KT) success depends on adhering to immunosuppressive medication post-transplant.
Objectives: To investigate whether adherence post-kidney transplantation (KT) and patients' attitudes toward immunosuppression were influenced by their prior dialysis type modality.
PLoS One
January 2025
Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Immunologic bile duct destruction is a pathogenic condition associated with vanishing bile duct syndrome (VBDS) after liver transplantation and hematopoietic stem-cell transplantation. As the bile acid receptor sphingosine 1-phosphate receptor 2 (S1PR2) plays a critical role in recruitment of bone marrow-derived monocytes/macrophages to sites of cholestatic liver injury, S1PR2 expression was examined using cultured macrophages and patient tissues. Bile canaliculi destruction precedes intrahepatic ductopenia; therefore, we focused on hepatocyte S1PR2 and the downstream RhoA/Rho kinase 1 (ROCK1) signaling pathway and bile canaliculi alterations using three-dimensional hepatocyte culture models that form obvious bile canaliculus-like networks.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!